publication venue for
- Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer. 123:36-42. 2019
- The trajectory of people who die from metastatic prostate cancer: A population-based study.. 123. 2018
- Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria - Australia. 117:45-49. 2016
- Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial. 115:35-45. 2015
- Patterns of care for metastatic renal cell carcinoma in Australia. 116:36-41. 2015
- Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. 113:77-83. 2014
- Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy. 112:46-52. 2013
- Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England. 108:E184-E189. 2011
- Effects of bariatric surgery on urinary and sexual function. 107:88-94. 2011
- National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index. 105:373-379. 2010
- ANTIBIOTICS FOR TRANSRECTAL ULTRASONOGRAPHY-GUIDED PROSTATE BIOPSY: ARE WE PRACTISING EVIDENCE-BASED MEDICINE?. 101:1202-1204. 2008
- Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship. 97:916-922. 2006
- Positron emission tomography and molecular imaging of the prostate: an update. 97:923-931. 2006
- An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy. 97:758-761. 2006
- Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography. 96:540-546. 2005
- Epithelial estrogen receptor a (ER alpha) regulates the proliferation of prostate cancer cells 2013
- Prioritising care for newly diagnosed men with prostate cancer: Development of a supportive care needs risk factor assessment tool 2013
- Robotic-assisted laparoscopic prostatectomy vs open radical prostatectomy: the "real life" patient reported outcomes 2018
- A comparison of 11C-choline PET with T2-weighted MRI for localizing malignant intraprostatic lesions for guiding prostate cancer focal therapies 2014
- PET/CT predicts mortality in muscle invasive bladder cancer 2013
- The experiences of gay and bisexual men diagnosed with prostate cancer: Results from an online focus group 2013
- Positron emission tomography-computed tomography (PET-CT) role in predicting mortality in patients with metastatic bladder cancer 2012
- In-vivo imaging of cellular proliferation in renal cell carcinoma using [18]F fluorothymidine PET 2010
- In vivo measurement of hypoxia in a renal cell carcinoma xenograft model 2009
- The role of interventional radiology in the management of renal trauma: five year experience in a level I trauma centre 2009
- In vivo molecular imaging of proliferation in renal cell carcinoma using F-18-fluorodeoxythymidine (FLT) positron emission tomography 2007
- A novel method for transplanting a reproducible volume of xenograft tumour beneath the renal capsule using automated biopsy equipment and an epidural needle 2006
- In vivo tumour hypoxia and carbonic anhydrase IX expression in xenografted human renal cell carcinoma animal models using probes, I-124-G250 pet, biodistribution and immunohisto-chemistry immunobiodistribution, and oxygen studies 2006
- Serum osteopontin - a new tumour marker in renal cell carcinoma 2005
- Examining completeness and agreement of comorbidity data obtained from administrative data, medical records and selfâreports by men diagnosed with prostate cancer undergoing radical prostatectomy 2019
- A novel framework for automated, intelligent extraction and analysis of online support group discussions for cancer related outcomes. 120:59-61. 2017
- Is choline-based PET imaging still relevant in recurrent prostate cancer?. 120:303-304. 2017